Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-01-28Clinical Trial Update: A 24-week Study of Fluticasone Furoate/Vilanterol Inhalation Powder in Subjects of Asian Ancestry With COPD [Phase 3]
Phase 3 24-week study results for the inhaled combination of fluticasone furoate and vilanterol in subjects of Asian ancestry with chronic o…
-
CLINICAL_TRIALS research · 2014-01-24Clinical Trial Update: Evaluation of a Regional Electronic Health Information Exchange's Clinical Health Record
This clinical trial update describes an evaluation of a regional electronic health information exchange's impact on the clinical health reco…
-
CLINICAL_TRIALS trial_result · 2014-01-23Clinical Trial Update: Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of caspofungin for invasive pulmonary aspergillosis in patients with chronic obstr…
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Extracorporeal CO2 Removal in COPD Exacerbation [Phase 2]
A Phase 2 clinical trial evaluating extracorporeal CO2 removal in COPD exacerbation has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Evaluating Sequential Strategies to Reduce Readmission in a Diverse Population [NA]
This clinical trial update notes the completion of a study evaluating sequential strategies to reduce hospital readmission in a diverse popu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-01-21FDA Approved: VENTOLIN HFA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Ventolin HFA (albuterol sulfate) from GlaxoSmithKline, expanding the labeling per the supplement…
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Pharmacovigilance Study to Evaluate Safety of SERETIDE in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Pharmacovigilance study evaluating the safety of SERETIDE in participants with chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-17Clinical Trial Update: Efficacy of AZD3199 in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 2]
Phase 2 trial results evaluating AZD3199 in chronic obstructive pulmonary disease have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: Long-term Effects of Non-invasive Ventilation in Hypercapnic Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 2]
Phase 2 trial evaluating the long-term effects of non-invasive ventilation in hypercapnic COPD has been terminated. Sponsor: FLUIDDA nv.
-
CLINICAL_TRIALS research · 2014-01-15Clinical Trial Update: Evaluation of Breathe NIOV System on Work of Breathing in Chronic Obstructive Lung Disease Patients [NA]
A clinical trial update on evaluating the Breathe NIOV System for reducing work of breathing in chronic obstructive pulmonary disease patien…
-
CLINICAL_TRIALS trial_result · 2014-01-15Clinical Trial Update: STRETCH OF RESPIRATORY MUSCLES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating stretching of respiratory muscles in chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Physical Training and Heart Rate Variability in COPD [NA]
This update reports the completion of a clinical trial investigating the impact of physical training on heart rate variability in individual…
-
FDA approval · 2014-01-08FDA Approved: ALBUTEROL SULFATE HFA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for ALBUTEROL SULFATE HFA from Teva Pharmaceuticals USA, Inc. This action relates to a regulator…
-
CLINICAL_TRIALS trial_result · 2014-01-08Clinical Trial Update: Indacaterol Versus Tiotropium on Dynamic Hyperinflation in COPD [Phase 4]
Phase 4 trial comparing indacaterol with tiotropium in COPD assessing dynamic hyperinflation; study status is completed.
-
CLINICAL_TRIALS withdrawal · 2014-01-08Clinical Trial Update: Thoracic Lymphatic Pump Techniques for Reducing Lung Volumes in Persons With Chronic Obstructive Pulmonary Disease [NA]
The trial evaluating thoracic lymphatic pump techniques to reduce lung volumes in chronic obstructive pulmonary disease has been withdrawn.
-
FDA approval · 2014-01-03FDA Approved: VENTOLIN HFA — Supplemental Application (GlaxoSmithKline LLC)
FDA approves a supplemental application for Ventolin HFA (albuterol sulfate) filed by GlaxoSmithKline LLC.
-
CLINICAL_TRIALS trial_result · 2013-12-30Clinical Trial Update: A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In COPD Patients. [Phase 2]
Phase 2 study evaluating the effect of inhaling a single dose of GW642444M in patients with chronic obstructive pulmonary disease; results w…
-
CLINICAL_TRIALS trial_result · 2013-12-30Clinical Trial Update: Effects of Sulfur Thermal Water Inhalation on Airway Oxidative Stress in COPD Patients [NA]
A completed clinical trial evaluated the effects of sulfur thermal water inhalation on airway oxidative stress in COPD patients.
-
CLINICAL_TRIALS trial_result · 2013-12-27Clinical Trial Update: Study of Trospium Chloride Inhalation Powder (TrIP) in Patients With Chronic Obstructive Pulmonary Disease [Phase 1, Phase 2]
This is a clinical trial update on Trospium Chloride Inhalation Powder (TrIP) for chronic obstructive pulmonary disease, covering Phase 1 an…
-
CLINICAL_TRIALS trial_result · 2013-12-25Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Profiles of 3 Doses of Fluticasone Furoate (FF)/GW642444 Inhalation Powder at the End of a 28-day Treatment Period in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Compared to Placebo [Phase 3]
Phase 3 trial evaluating three doses of Fluticasone Furoate with GW642444 inhalation powder versus placebo in COPD patients over 28 days, as…
-
CLINICAL_TRIALS trial_result · 2013-12-25Clinical Trial Update: A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium [Phase 4]
A Phase 4 clinical trial update evaluated day-to-day changes in lung function in COPD patients taking albuterol (salbutamol) and ipratropium…
-
CLINICAL_TRIALS trial_result · 2013-12-24Clinical Trial Update: The Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 clinical trial evaluated the effect of the indacaterol/glycopyrronium (QVA149) combination on patient-reported dyspnea in moderate…
-
CLINICAL_TRIALS trial_result · 2013-12-23Clinical Trial Update: Strategy to Improve Adherence of Roflumilast [Phase 4]
A Phase 4 clinical trial update describes strategies to improve adherence to roflumilast in patients with chronic obstructive pulmonary dise…
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Deep High-Frequency Repetitive Transcranial Magnetic Stimulation for Smoking Cessation [Phase 2, Phase 3]
The clinical trial updates report completion of Phase 2 and Phase 3 studies evaluating deep high-frequency repetitive transcranial magnetic …
-
FDA approval · 2013-12-18FDA Approved: UMECLIDINIUM AND VILANTEROL ELLIPTA — Original Application (Prasco Laboratories)
The FDA approved Prasco Laboratories' original application for umeclidinium bromide and vilanterol Ellipta, a combined LAMA/LABA inhalation …